Effect of Natriuretic Peptide Receptor Antagonist on Lipopolysaccharide-induced Fever in Rats: is Natriuretic Peptide an Endogenous Antipyretic?
From: Division of Integrative Physiology, Department of Functional, Morphological, and Regulatory Science, Tottori University, Faculty of Medicine, Yonago, Tottori 683, Japan.
The Journal of pharmacology and experimental therapeutics
- Publish Date: Sep 2006
- ISSN: 0022-3565
- Volume: 318
- Issue: 3
- Pages: 1163-70
- Medium: Print
- Language: English
- Citation (JAMA): Miyoshi Michio, Kitagawa Yoshinori, Imoto Toshiaki, et al. Effect of Natriuretic Peptide Receptor Antagonist on Lipopolysaccharide-induced Fever in Rats: is Natriuretic Peptide an Endogenous Antipyretic?. J. Pharmacol. Exp. Ther. Sep 2006;318:1163-70
Abstract
We investigated whether natriuretic peptide (NP) acts as an endogenous antipyretic inside and/or outside the blood-brain barrier in rats made febrile by systemic administration of bacterial endotoxin (lipopolysaccharide; LPS). Intravenous (i.v.) injection of LPS induced a triphasic fever, the second phase of which was significantly enhanced by an i.v. injection of the NP receptor (A-type and B-type) antagonist HS-142-1, a glucose-caproic acid polymer. In contrast, the same antagonist (i.v.) had no effect on the fever induced by i.v. injection of interleukin (IL)-1beta. An i.v. administration of HS-142-1 enhanced the LPS (i.v.)-induced IL-1beta response in the rat spleen. An i.v. treatment with atrial NP (ANP) significantly attenuated the second phase of the LPS-induced fever. On the other hand, i.c.v. injection of the above-mentioned NP receptor antagonist resulted in an augmentation of the third phase of the fever induced by i.v. administration of LPS, the same phase that was attenuated by ANP given i.c.v. When given intracerebro-ventricularly (i.c.v.), the antagonist had no effect on the fever induced by i.v. IL-1beta. Finally, the fever induced by i.c.v. injection of LPS was not affected even by an i.c.v. administration of the antagonist. These results suggest that the production of pyrogenic cytokines (such as IL-1beta) that follows i.v. LPS injection may be inhibited by NP acting outside the blood-brain barrier, leading to an inhibition of the fever. In contrast, inside the blood-brain barrier NP may inhibit cytokine-independent mechanisms present within the rat brain that mediate LPS (i.v.)-induced fever.
Mesh Headings (Keywords): Animals, Atrial Natriuretic Factor, Body Temperature, Fever, Guanylate Cyclase, Interleukin-1, Lipopolysaccharides, Male, Natriuretic Peptides, Polysaccharides, Rats, Rats, Wistar, Receptors, Atrial Natriuretic Factor
Check for Full Text / PubMed Unique Identifier (PMID): 16751254
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.